Miami, FL

Nuren Medical and Research Center

Ulcerative Colitis

Colitis

Ulcer

Crohn Disease

Communicable Diseases

Infections

Helicobacter Infections

Esophagitis

Chronic Kidney Failure

Atrial Fibrillation

Lansoprazole

Ontamalimab

Vonoprazan

warfarin

apixaban

EDP-235

SHP647

Shire

Phathom Pharmaceuticals

Enanta Pharmaceuticals

Christopher Granger, MD

condition

COVID-19

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

Study of EDP-235 in Non-hospitalized Adults with Mild or Moderate COVID-19.

A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19

Nuren Medical and Research Center | Miami, FL

Site insights

Work at this site?

Active trials

A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19 (SPRINT)

Trial sponsors